b-D-Glucopyranuronic acid,1-[5-[4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl][1,1'-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy- (160205-58-3)

Identification
Name:	b-D-Glucopyranuronic acid,1-[5-[4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl][1,1'-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-
CAS:	160205-58-3
Molecular Formula:	C31H36 N6 O7
Molecular Weight:	0
InChI:	InChI=1/C31H36N6O7/c1-2-3-10-22-32-31(15-6-7-16-31)30(43)36(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)27-33-35-37(34-27)28-25(40)23(38)24(39)26(44-28)29(41)42/h4-5,8-9,11-14,23-26,28,38-40H,2-3,6-7,10,15-17H2,1H3,(H,41,42)/t23-,24-,25-,26?,28+/m1/s1
Molecular Structure:
Properties
Refractive index:	1.728
Usage:	A metabolite of Irbesartan (M8)
Safety Data

Other Product

[1,1'-Biphenyl]-2-carbonitrile,4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-
[1,1'-Biphenyl]-2-carboxylic acid,4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]- non-1-en-3-yl)methyl]-,mono(trifluoroacetate)
b-D-Glucopyranuronic acid,1-[5-[2-[3-bromo-5-[(2-butyl-5-carboxy-4-chloro-1H-imidazol-1-yl)methyl]-2-benzofuranyl]phenyl]-2H-tetrazol-2-yl]-1-deoxy-
1,3-Diazaspiro[4.4]non-1-en-4-one,2-butyl-
1,3-Diazaspiro[4.4]non-1-en-4-one,2-methyl-
Benzenesulfonamide,4-[3-(4-fluorophenyl)-2-oxo-1-oxaspiro[4.4]non-3-en-4-yl]-
4'-(2-Butyl-4-oxo-1,3-diazaspiro[4.4]-1-nonen-3-ylmethyl)-N-(3,4-dimethylisoxazol-5-yl)-2'-(3,3-dimethyl-2-oxopyrrolidin-1-ylmethyl)biphenyl-2-sulfonamide
Cyclopentanecarbothioamide,1-[methyl[1-methyl-4-[(phenylmethyl)imino]-1,3-diazaspiro[4.4]non-2-en-2-yl]amino]-N-(phenylmethyl)-
1-Oxa-2,7-diazaspiro[4.4]non-2-ene-8-carboxamide,3-(5-chloro-2,4-dimethoxyphenyl)-N-[1-(cyclobutylmethyl)-3-(cyclopropylamino)-2,3-dioxopropyl]-7-[(2S)-3,3-dimethyl-1-oxo-2-[[2-(tetrahydro-2H-pyran-4-yl)acetyl]amino]butyl]-, (5S,8S)-
b-D-Glucopyranuronic acid,1-[(4'-amino[1,1'-biphenyl]-4-yl)amino]-1-deoxy-
1H-Imidazo[4,5-c]quinoline,4-chloro-2-(ethoxymethyl)-1-[2-(3-methyl-1-oxa-2,4-diazaspiro[4.4]non-2-en-4-yl)ethyl]-
b-D-Glucopyranuronic acid,1-[[4-[(4-amino-3-chlorophenyl)methyl]-2-chlorophenyl]amino]-1-deoxy-
b-D-Glucopyranuronic acid,1-deoxy-1-[(3-methyl-3H-imidazo[4,5-f]quinolin-2-yl)amino]-
1,3-Diazaspiro[4.4]non-1-en-4-one,2-propyl-
1,3-Diazaspiro[4.4]non-1-en-4-one,2-phenyl-
1,3-Diazaspiro[4.4]non-1-en-4-one,2-butyl-, hydrochloride (1:1)
b-D-Glucopyranuronic acid,1-[(6-cyclohexyl-4-methyl-2-oxo-1(2H)-pyridinyl)oxy]-1-deoxy- (9CI)
1-Piperidinecarboxylic acid,4-cyclohexyl-4-[(2-oxo-3-oxa-1-azaspiro[4.4]non-1-yl)methyl]-,1,1-dimethylethyl ester
3-Thiophenecarboxylicacid,2-[[4-butyl-2-methyl-6-oxo-5-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1(6H)-pyrimidinyl]methyl]-,methyl ester
3H-Imidazo[4,5-b]pyridine,2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, sodium salt(1:1)